Agmatine Sulfate Dosage & Cost Calculator

Use this calculator to plan how many Nootropics Depot Agmatine Sulfate 250mg capsules and bottles you’ll need for a given time period, and see the estimated cost based on the current 240-count bottle price.

Agmatine Sulfate Dosage & Cost Calculator

Based on the labeled dose options for Nootropics Depot Agmatine Sulfate 250mg and the published 240-count bottle at $37.99.

Units needed
Bottles (240ct)
Est. total cost
Cost / day at this dose

Estimate only – based on the current listed price of the 240-count Nootropics Depot Agmatine Sulfate 250mg bottle. Actual Amazon price can change; check the live price before buying.

Why no height/weight input? Unlike per-kg supplements (creatine, protein), Agmatine Sulfate has no published bodyweight-adjusted dosing in the research behind it. This calculator doesn't fabricate a per-kg formula that doesn't exist in the literature.

Get Nootropics Depot Agmatine Sulfate 250mg on Amazon

(paid link) As an Amazon Associate we earn from qualifying purchases.

This product’s label lists 250–500 mg/day (1–2 capsules), taken as a single dose or split, which matches general agmatine dosing guidance for nootropic/pre-workout use.

It’s worth being clear about what the clinical research actually studied: the most rigorous human trial of agmatine sulfate used a much higher dose — 2.67 g/day (2,670 mg, roughly 10–11 capsules of this product) — in a randomized, placebo-controlled trial of patients with lumbar disc-associated radiculopathy (a specific nerve-pain condition), not general wellness or workout use [1]. That trial’s dose and use case don’t translate to the 250–500 mg/day general supplement range, so this calculator sticks to the label’s own dose options rather than the clinical-trial dose.

As with the other calculators on our network, there’s no published bodyweight-adjusted dosing for agmatine, so this tool plans by a fixed daily amount rather than your height or weight.

References

  1. Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy: An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial. Pain Medicine, 2010
Scroll to Top
© 2026 AgmatineHub — Health Disclaimer  |  Affiliate Disclosure  |  Privacy Policy  |  Terms  |  About
As an Amazon Associate we earn from qualifying purchases.